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Abstract
Background: Obstructive sleep apnea (OSA) is a common disorder, and continuous airway positive pressure (CPAP)
is considered to be the gold standard of therapy. CPAP however is known to have problems with adherence, with
many patients eventually abandoning the device. The purpose of this paper is to assess secular trends in CPAP
adherence over the long term to see if there have been meaningful improvements in adherence in light of the
multiple interventions proposed to do so.
Methods: A comprehensive systematic literature review was conducted using the Medline-Ovid, Embase, and
Pubmed databases, searching for data regarding CPAP adherence over a twenty year timeframe (1994–2015). Data
was assessed for quality and then extracted. The main outcome measure was reported CPAP non-adherence.
Secondary outcomes included changes in CPAP non-adherence when comparing short versus long-term, and
changes in terms of behavioral counseling.
Results: Eighty-two papers met study inclusion/exclusion criteria. The overall CPAP non-adherence rate based on a
7-h/night sleep time that was reported in studies conducted over the twenty year time frame was 34.1 %. There
was no significant improvement over the time frame. Behavioral intervention improved adherence rates by ~1 h
per night on average.
Conclusions: The rate of CPAP adherence remains persistently low over twenty years worth of reported data. No
clinically significant improvement in CPAP adherence was seen even in recent years despite efforts toward
behavioral intervention and patient coaching. This low rate of adherence is problematic, and calls into question the
concept of CPAP as gold-standard of therapy for OSA.
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Background
Obstructive sleep apnea (OSA) is a common disorder af-
fecting 3–9 % of the general population and is well dem-
onstrated to be a risk factor for resistant hypertension,
fatal and non-fatal cardiovascular disease, neurological
disease, and all-cause mortality [1]. OSA has predictable
effects on decreasing economic outcomes, and is also a
source of car accidents [1, 2]. Since the pervasive
health effects of untreated OSA are so well described,
practice parameters published by the American Acad-
emy of Sleep Medicine (AASM) recommend that con-
tinuous positive airway pressure (CPAP) should be
considered both first-line and gold-standard treatment
for OSA; many prominent published studies make
similar statements [2–5].
When used as prescribed, CPAP reduces daytime
sleepiness, normalizes sleep architecture, and improves
numerous OSA-specific health outcomes [6]. The sense
of CPAP being considered gold standard of therapy has
become so entrenched within health that many North
American remunerating agencies, be they government
insurance or private plans, as well as in the medicolegal
world, have adopted the position that patients must
undergo a trial of CPAP prior to being considered for
any other more invasive intervention. However, the
AASM parameters also recognized that a significant pro-
portion of patients are unable to tolerate CPAP therapy,
and frequently seek alternate treatment [2].* Correspondence: drkpang@gmail.com2Asia Sleep Centre, Paragon, 290, Orchard Road, Unit 18-04, Singapore
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Despite numerous advances in machine dynamics in-
cluding quieter pumps, softer masks, and improved
portability, adherence to CPAP continues to be a prob-
lem frequently encountered in clinician’s offices, with
adherence rates generally ranging from 30 to 60 % [7, 8].
There are many reasons for this problem including com-
fort, convenience, claustrophobia, and cost. [2] It is also
understood that many patients who start on a path to
non-adherence frequently remain non-adherent and
eventually abandon the machine altogether, with conse-
quent return of symptoms and OSA-specific adverse
consequences. Finally, although “optimal” adherence
rates in the literature range from 4 to 6 h per night, it is
becoming increasingly recognized that data used to de-
fine “optimal” or even “sufficient” use also very much re-
lated the outcome measure being studied as well as
patient self-perception of their own OSA severity. Until
recently such adherence data were underemphasized in
the CPAP literature, giving the medical community at
large a somewhat unrealistic sense of the effectiveness of
the device as a blanket treatment for all comers with
OSA. Perhaps consequently CPAP continues to stand at
the top of the treatment modality spectrum for OSA
despite the problematic shortcomings described above.
The purpose of the current study was to investigate
whether or not there has been a change in CPAP adher-
ence trends over the long term. This information is im-
portant when counseling patients about the likelihood of
treatment success when a CPAP prescription is given.
Methods
Our review was carried out in accordance with the
preferred reporting items for systematic review and meta-
analysis protocols (PRISMA-P) 2015 statement. A com-
prehensive systematic literature review was conducted
using the Medline-Ovid, Embase, and Pubmed databases.
The primary search objective was to identify all papers
reporting the results of clinical trials that used CPAP for
the treatment of adults with OSA, and then to subse-
quently extract data on adherence if it was reported. The
first step was a locate and review all of the studies listed
for analysis in two major literature reviews, a Cochrane
Collaboration review [9] and a second systematic litera-
ture review published by the National Institutes of
Health Research (NIHR) [10] on the use of CPAP for the
treatment of OSA. The second step was an extensive
search of the PubMed/MedLine database, initiated using
the following combined search terms (using both British
and American spellings): “CPAP and obstructive sleep
apnea” (n = 3058). From this list, studies were identified
that (a) did not replicate studies already found (b) were
otherwise eligible for inclusion and (c) comprise primary
data, i.e. not reviews or guidelines. The third and final
step was a review of all reference lists and tables of other
studies found within papers identified in the second step.
A PhD level biostatistician performed all three of the ini-
tial search steps. EBM rankings were used to assess data
quality.
Articles were considered for inclusion into the study
by reviewing the titles and abstracts of all retrieved stud-
ies. The senior study authors BWR and KPP did this and
results were compiled to ensure no studies were missed.
The full text of selected studies were then analyzed to
ensure that the following inclusion criteria were met:
diagnosis of OSA, no confounding data for central sleep
apnea, and the paper referred to CPAP for treatment of
OSA. Subsequently we reviewed the studies to ensure
adherence data was reported, and that if reported it was
by machine audit as opposed to patient-self-report.
Results
A total of 82 papers were identified for analysis.
These included trials comparing CPAP versus sub-
therapeutic (sham) CPAP [11–41], CPAP versus an
oral placebo [40, 42–49], CPAP versus conservative or
no therapy [17, 29, 50–60], CPAP versus an oral ap-
pliance [11, 12, 42, 57, 61–69], CPAP versus postural
therapy [70–73], and CPAP alone assessing different means
to modify adherence [15, 27, 37, 74–82]. The PRISMA
chart summarizing the study flow is seen in Fig. 1.
Overall CPAP adherence over the study duration
Sixty-six studies published between 1994 and 2015,
inclusive, were identified in the literature that had
CPAP adherence data reported as hours of use per
night and were either a randomized clinical trial or a
longitudinal cohort study specifically addressing the
issue of CPAP adherence in adult patients with OSA.
Sample sizes in these studies ranged from 13 to 356
(mean = 65, median = 37) subjects. The mean, non-
weighted duration of nightly use was 4.6 h, from
which the percentage of non-use, relative to optimum
use, was calculated by subtracting 4.6 from 7.0 h, div-
iding this by 7.0 h and converting to a percentage; in
this instance 34.1 % (i.e. the non-adherence rate). The
weighted mean for nightly CPAP use was calculated
by multiplying the mean use for each individual study
by the number of CPAP users in that study, adding
the resulting values from all 66 studies, and then div-
iding by the total number of subjects on CPAP across
all studies; this yielded a weighted mean nightly CPAP
use and percentage of use of 4.46 h/n and 36.3 %,
respectively.
Figure 2 depicts both the weighted and non-weighted
mean percentage of non-use for all studies within each
2-year block starting with 1996–97. To incorporate stud-
ies from 2014, the final block, 2012–14, consists of
3 years. Note the initial decline in non-adherence from
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Fig. 2 Graph showing percentage adherence over the years
Fig. 1 Prism chart showing article selection process
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1996 to 97 through 2000–01, after which there is no de-
cline. In fact, non-adherence for 2012–14 was higher
than for any other time period from 2000 to 01 onwards,
possibly reflecting improved data reporting. Note also
the almost identical curves for non-weighted and
weighted data.
Adherence when comparing short-term versus long-term
Eight studies were identified that had follow-up CPAP
adherence assessments, including hours of CPAP use
per night, 6 months or more since baseline, versus 64
studies with final assessments performed within the first
6 months. Again, both weighted and non-weighted
means were calculated for mean nightly CPAP use and
mean percentage of time CPAP was not used relative to
the optimum 7.0 h per night. For the short-term studies,
mean non-weighted and weighted mean values are 4.5
and 4.3 h/night, and 35.5 and 38.4 % CPAP non-use, re-
spectively. Corresponding values for the long-term stud-
ies are 4.6 and 4.6, and 34.2 and 33.6 %, indicating
slightly superior adherence at follow-up assessments
performed in patients on CPAP for 6 months or more.
This is reflected in Fig. 3.
Adherence rates in self-report versus machine-
interrogation
This analysis was restricted to studies in which measure-
ments were made comparing both self-reported versus
device-documented CPAP adherence values [79, 82]. In
both studies, adherence was over-estimated by self-
report, as summarized in Table 1. Note that for one of
the studies, ‘percentage of adherence’ was the utilized
measure of CPAP adherence, with adherence defined as
four or more hours of use per night for 70 % or more of
nights. For the other study, mean hours use per night was
presented. The non-weighted percentage of self-reported
over-estimation (relative to machine-documented use)
ranged from roughly 25 to 50 %, averaging 35.4 %.
Adherence rates versus behavioral intervention
Several RCTs were identified in which some behavioural
intervention was evaluated in terms of its ability to im-
pact CPAP adherence, measured as hours of CPAP use
per night [84–90], Although increased use was docu-
mented in three studies [84–86], four RCT did not find
support for the behavioural intervention [87–90]. Table 2
summarizes these results.
Discussion
CPAP is termed the gold standard for therapy of OSA
and indeed when used as prescribed the health benefits
are substantial. However this modality of treatment con-
tinues to be plagued by problems with adherence. The
data identified in our review is the most up-to-date on
the topic, and suggests that despite numerous interven-
tions designed to improve adherence rates over the long
term, secular trends do not show clinically impactful
changes. The relatively poor adherence rates pre-2000
have not shown meaningful improvement over the en-
suring 15 years, with overall rates stubbornly persistent
at a high 30–40 % non-adherence.
The further problem identified by our data is that of
the reporting of CPAP in clinical trials. In our review of
82 CPAP trials, 10.7 % of patients overall were unable to
tolerate and thereby remain on CPAP over the duration
of the trial in which they were participants, and the
mean duration of nightly use was merely 4.7 h. This
Fig. 3 Bar chart showing percentage adherence cpmaring weight and non-weightedsubjects in the study
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means that the average patient in bed for 7 h across
these 83 closely supervised clinical trials (i.e. under the
most optimal of circumstances and the best chance for
success at the therapy) was not using it an average of
32.9 % of the time; extrapolating to 8-h nights, this time
off CPAP rises to 41.3 %. When the nights per week of
CPAP non-use have been examined, the percentages
range from 10 to 40 % [12, 44, 56, 61, 70, 74–76], with
one in three out of 25 patients in a very brief, 2-week
cross-over trial by Ferguson et al. only using CPAP one
out of every three nights or less [62]. These are highly
alarming percentages, given that several published RCT
have documented that at least a minimum level of CPAP
use is required to reap benefits from it and that this
therapeutic threshold generally falls between 5 and 6 h
nightly [16, 43, 45, 74, 77]. It is, therefore, reasonable to
assume that there is a sizeable subset, possibly a major-
ity, of patients on CPAP who either cease to use it
altogether, or fail to use it enough hours per night and/
or nights per week to achieve clinically-significant bene-
fits. This does call into question the validity of the re-
sults of some of these trials.
Prior to our study, Weaver et al. conducted the most
recent prior review on CPAP as therapy for OSA in
2010, finding that there are many factors influencing
CPAP adherence, both medical and non-medical (e.g.
psychosocial), and that these need to be considered
when both prescribing CPAP as well as designing effect-
ive interventions to improve adherence [7]. The authors
wisely also pointed out that the cost-effectiveness of
these interventions needs to be considered.
The most recent comprehensive literature review of
CPAP adherence looks to be by Donovan et al. [91]. The
authors investigated various outcomes including CPAP
efficacy, behavioral interventions, and personalizing
CPAP to patient need. The authors maintained that its
main limitation is intolerability, which leads to low ad-
herence. The authors call for more research on tailoring
therapies to individual patients in order to enhance
adherence.
The long-term effects of non-adherence bring to
light the health related impact of untreated OSA. It is
not sufficient to simply prescribe a CPAP machine
and consider the patient to be treated. For example,
BaHammam et al. [92] found that adherence to CPAP
declined over a 10-month period, such that only 33 % of
the OSA patients were considered to have “good adher-
ence” by 10 months, even after receiving an educational
intervention. Gagnadoux et al. [93] found that AHI scores
and socioeconomic factors (employment and marital sta-
tus) predicted mean CPAP adherence over several 6-
month follow-up assessments. Martinez-Garcia et al. [94]
follow a sample of older adults who were prescribed CPAP
for up to 10 years and found that severe OSA not treated
with CPAP was associated with a higher risk of cardiovas-
cular death, and CPAP use decreased this risk (albeit non
significantly). Stuck et al. [95] conducted a retrospective
chart review of 750 patients who were prescribed CPAP
and follow-up over a 2-year period to quantify several
sleep-related events such as hours of sleep without CPAP,
and the number of respiratory events with and without
CPAP. These authors concluded that CPAP has a limited
effectiveness, even among patients who are most adherent
to treatment.
Although a detailed discussion of the effectiveness of
interventions to improve CPAP adherence is beyond the
Table 1 Studies comparing self-reported vs. machine-documented CPAP compliance
1st author (year) Outcome Subjects (N) Self-report CPAP device Absolute difference Percent difference
Roecklein (2010) [79] Hours per night at 3 months 28 4.68 2.35 2.33 49.8 %
Kribbs (1993) [83] Hours per night over time 35 4.9 3.7 1.2 24.5 %
311 Mean = 35.4 %
Weighted mean = 32.7 %
Table 2 CPAP adherence versus behavioral intervention
1st author (year) Study design Subjects (N) Intervention Follow-up CPAP use (h/n) Significance
Rx group Controls
Lo Bue (2014) [99] RCT 20/20 “Reinforcing interventions” 1 year 4.3 3.8 NS
Lai (2014) [100] RCT 50/50 Motivational enhancement 3 months 4.4 2.4 p < 0.001
Deng (2013) [101] RCT 55/55 Stage-matched vs. standard care 3 months 5.65 5.26 p = 0.006
Olsen (2012) [102] RCT 50/50 3 motivational interviews 3 months 4.63 3.16 p = 0.005
Roecklein (2010) [79] RCT 13/15 Personalized feedback 3 months 2.35 1.97 NS
Mean 4.3 3.3 28.6 % ↑
Weighted mean 4.7 3.5 32.0 % ↑
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scope of this current paper, several of the papers studied
in our review did investigate these interventions [79, 92],
including one review [96]. The strongest intervention,
cognitive-behavioral, resulted in an increase of 1.44 h
per night for participants in six studies. Both supportive
and educational interventions were found to increase
adherence to over 4 hours per night among study partici-
pants. Non-behavioral interventions for CPAP adherence,
such as variants of CPAP, have also been investigated. A
systematic review and meta-analysis found that patients
preferred auto-CPAP over fixed pressure CPAP; however,
there was no statistical difference in machine use [97].
Overall the authors did not find a difference in adherence
between auto- and fixed-CPAP. Similarly, a more recent
systematic review and meta-analysis found positive results
associated with auto-CPAP over fixed-CPAP, including pa-
tient preference and enhanced adherence [98]. However,
the latter did not found significant differences between
the two variants in terms of AHI and ESS scores, leading
the authors to question the clinical significance of their
results.
As a systematic review, this study is limited to the
quality of the included studies. Because it is a collection
of findings from various other studies, it provides an
overview of the direction of literature but is unable to
show new findings. The authors recognize that in one
study, CPAP was prescribed in patients with mild OSA,
this might suggests that these patients who have no sig-
nificant symptoms might not be compelled to use their
CPAP device. It is also understandable that some pa-
tients may not sleep 7 h per night, as they are the work-
ing class group and may be too busy, and this might also
affect the compliance percentage as the denominator is
smaller. The older age group may have fragmented sleep
patterns while the younger age group may not choose to
wear their CPAP for social reasons. This study is also
limited in the fact that only English language articles are
considered, which may introduce a language bias. How-
ever, studies are published from a variety of centers
internationally. Because this study is not a meta-analysis,
study results have not been statistically combined for
more powerful results. However, since adherence rates
to CPAP are often measured differently, as are the de-
fined outcome points for success, it is not feasible to dir-
ectly compare papers in a statistically sound method.
Conclusion
This review represents the most up to date data on secu-
lar trends in CPAP adherence. The findings are sobering.
Our data suggest that despite numerous changes to ma-
chine and mask dynamics as well as behavioral interven-
tions, CPAP adherence remains a severe problem for
management of patients with OSA - the concept of
CPAP as gold standard for OSA therapy is no longer
valid. This paper’s data regarding a comprehensive as-
sessment of CPAP adherence can be used when develop-
ing OSA treatment guidelines and when counseling
patients about their OSA and the relative likelihood of
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